XML 9 R3.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Restricted cash $ 109,542 $ 43,371
Deferred financing costs $ 39,880 $ 28,306
Common shares, par value $ 0.001 $ 0.001
Common shares, issued 143,143,972 140,208,028
Common shares, outstanding 143,143,972 140,208,028
Non-controlled, Non-affiliated Investments    
Investments at amortized cost $ 7,203,329 $ 7,079,994